These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17100636)

  • 1. Glycolipids as immune modulatory tools.
    Lalazar G; Preston S; Zigmond E; Ben Yáacov A; Ilan Y
    Mini Rev Med Chem; 2006 Nov; 6(11):1249-53. PubMed ID: 17100636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis.
    El Haj M; Ben Ya'acov A; Lalazar G; Ilan Y
    World J Gastroenterol; 2007 Nov; 13(44):5799-804. PubMed ID: 17990345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of natural killer T cells in antitumor immunotherapy.
    Hong C; Park SH
    Crit Rev Immunol; 2007; 27(6):511-25. PubMed ID: 18197797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
    Hung JT; Huang JR; Yu AL
    J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells.
    Wu D; Xing GW; Poles MA; Horowitz A; Kinjo Y; Sullivan B; Bodmer-Narkevitch V; Plettenburg O; Kronenberg M; Tsuji M; Ho DD; Wong CH
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1351-6. PubMed ID: 15665086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKT cell responses to glycolipid activation.
    Tefit JN; Davies G; Serra V
    Methods Mol Biol; 2010; 626():149-67. PubMed ID: 20099127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of immune responses by CD1d-restricted natural killer T cells.
    Van Kaer L
    Immunol Res; 2004; 30(2):139-53. PubMed ID: 15477656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.
    Schiefner A; Fujio M; Wu D; Wong CH; Wilson IA
    J Mol Biol; 2009 Nov; 394(1):71-82. PubMed ID: 19732779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
    Maricic I; Girardi E; Zajonc DM; Kumar V
    J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of invariant natural killer T (iNKT) cells in systemic lupus erythematosus.
    Godó M; Sessler T; Hamar P
    Curr Med Chem; 2008; 15(18):1778-87. PubMed ID: 18691038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells.
    Elewaut D; Lawton AP; Nagarajan NA; Maverakis E; Khurana A; Honing S; Benedict CA; Sercarz E; Bakke O; Kronenberg M; Prigozy TI
    J Exp Med; 2003 Oct; 198(8):1133-46. PubMed ID: 14557411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.
    Miyamoto K; Miyake S; Yamamura T
    Nature; 2001 Oct; 413(6855):531-4. PubMed ID: 11586362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocytic pH regulates cell surface localization of glycolipid antigen loaded CD1d complexes.
    Arora P; Kharkwal SS; Ng TW; Kunnath-Velayudhan S; Saini NK; Johndrow CT; Chang YT; Besra GS; Porcelli SA
    Chem Phys Lipids; 2015 Oct; 191():75-83. PubMed ID: 26306469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycolipid-activated NKT cells support the induction of persistent plasma cell responses and antibody titers.
    Devera TS; Shah HB; Lang GA; Lang ML
    Eur J Immunol; 2008 Apr; 38(4):1001-11. PubMed ID: 18350547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids.
    Parekh VV; Singh AK; Wilson MT; Olivares-Villagómez D; Bezbradica JS; Inazawa H; Ehara H; Sakai T; Serizawa I; Wu L; Wang CR; Joyce S; Van Kaer L
    J Immunol; 2004 Sep; 173(6):3693-706. PubMed ID: 15356115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Glycosphingolipids as immune modulators.
    Adar T; Ilan Y
    J Immunotoxicol; 2008 Apr; 5(2):209-20. PubMed ID: 18569392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids.
    Chang YJ; Huang JR; Tsai YC; Hung JT; Wu D; Fujio M; Wong CH; Yu AL
    Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10299-304. PubMed ID: 17566107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Endocytic pH regulates cell surface localization of glycolipid antigen loaded CD1d complexes".
    Arora P; Kharkwal SS; Ng TW; Kunnath-Velayudhan S; Saini NK; Johndrow CT; Chang YT; Besra GS; Porcelli SA
    Chem Phys Lipids; 2016 Jan; 194():49-57. PubMed ID: 26496152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.